GlaxoSmithKline’s CEO Emma Walmsley has said the company hopes ... Walmsley said there is a lot of data expected in 2020. Walmsley said in the interview that the next year could see “at ...
Walmsley was three years into her effort remaking ... Revenue increased 8% in the first half of 2020—powered by the growth of its consumer health division, largely owing to its merger with ...
Bloomberg on MSN9mon
GSK’s New Vaccine Kept the Boss in Her Job — and an Activist at Bay(Bloomberg) -- When Elliott Investment Management came calling for the ouster of Emma Walmsley, the chief executive officer ...
Hosted on MSN1mon
GSK CEO Optimistic About Dealmaking, Trump Administration(Bloomberg) -- GSK Plc’s Chief Executive Officer Emma Walmsley is looking to do more deals as the British drugmaker doubles down on its return to cancer medicines. While GSK already agreed to ...
GlaxoSmithKline’s new chief executive Emma Walmsley has unveiled her strategy ... to eliminate a further £1billion in savings by 2020. The company says it is sticking with its growth forecast ...
CEO Emma Walmsley says. Speaking at the CEO Times Summit in London, Walmsley highlights the U.K. pharmaceutical company's refocused R&D strategy, with investments concentrated in the U.K., U.S ...
Walmsley, the only woman CEO of a major pharma company, told Fortune at the time that GSK was working on building its vaccine portfolio. That’s not the only avenue where GSK is growing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback